Congenital afibrinogenemia: Identification and expression of a missense mutation in FGB impairing fibrinogen secretion

Blood

Volumn 102, Issue 13, 2003, Pages 4413-4415

  Vu, Dung ^b   Bolton Maggs, Paula H B ^b   Parr, Jeremy R ^b   Morris, Michael A ^b   De Moerloose, Philippe ^b   Neerman Arbez, Marguerite ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOGEN ALPHA; FIBRINOGEN BETA; UNCLASSIFIED DRUG;

AFIBRINOGENEMIA; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN METABOLISM; GENE DELETION; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; MALE; MISSENSE MUTATION; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PEDIGREE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTHROMBIN TIME;

EID: 0344305469     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-06-2141     Document Type: Article

References (17)

1. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol. 1999;107:204-206.
2. Rabe F, Salomon E. Ueber-faserstoffmangel im Blute bei einem Falle von Hämophilie. Arch Intern Med. 1920;95:2-14.
3. Kant JA, Fornace AJ Jr, Saxe D, Simon MI, McBride OW, Crabtree GR. Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci U S A. 1985;82:2344-2348.
4. Neerman-Arbez M, Honsberger A, Antonarakis SE, Morris MA. Deletion of the fibrinogen [correction of fibrogen] alpha-chain gene (FGA) causes congenital afibrogenemia. J Clin Invest. 1999;103:215-218.
5. Neerman-Arbez M. The molecular basis of inherited afibrinogenaemia. Thromb Haemost. 2001;86:154-163.
6. Duga S, Asselta R, Santagostino E, et al. Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood. 2000;95:1336-1341.
7. Duga S, Asselta R, Santagostino E, et al. Involvement of fibrinogen Bbeta-chain gene in the pathogenesis of congenital afibrinogenemia [abstract]. Thromb Haemost. 2001;86(suppl):P1108.
8. Antonarakis SE. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat. 1998;11:1-3.
9. Homer VM, Brennan SO, Ockelford P, George PM. Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia. Thromb Haemost. 2002;88:427-431.
10. Neerman-Arbez M, Vu D, Abu-Libdeh D, Bouchardy I, Morris MA. Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family. Blood. 2003;101:3492-3494.
11. Asselta R, Spena S, Duga S, et al. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bb-chain gene causing afibrinogenemia. Haematologica. 2002;87:855-859.
12. Neerman-Arbez M, de Moerloose P, Bridel C, et al. Mutations in the fibrinogen Aalpha gene account for the majority of cases of congenital afibrinogenemia. Blood. 2000;96:149-152.
13. Neerman-Arbez M, de Moerloose P, Honsberger A, et al. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes. Hum Genet. 2001;108:237-240.
14. Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet. 1999;8:1893-1900.
15. Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell. 1999;96:307-310.
16. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002;3:285-298.
17. Maghzal GJ, Brennan SO, Fellowes AP, Spearing R, George PM. Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bbeta255 Arg→His (Fibrinogen Merivale). Biochim Biophys Acta. 2003;1645:146-151.